The vaccine race: 5 Coronavirus Pharma actions to buy now
The Corona pandemic has hit the world. As countries continue to isolate themselves, it becomes clear that the development of a vaccine is now a top priority. The deciding factor here: Time.
The following companies are taking part in the race to develop a Covid-19 vaccine. Besides the public interest, there are also economic factors that require the vaccine to be approved on the market as soon as possible.
1. Glaxo Smith Kline
The British pharmaceutical giant GSK is one of the major players in the vaccination market. Vaccination against HPV (human papillomavirus) and various influenza vaccinations have already been put on the market by GSK. The company is currently providing vaccine development technologies to partner companies to rapidly develop a Covid-2019 vaccine.
2. Johnson and Johnson
The pharmaceutical division of the American multinational has already attracted attention in the past. For example, immunization technologies have been developed here to combat the Ebola virus. It is precisely these technologies that are now used to develop a Corona vaccine. To this end, Johnson and Johnson has partnered with the United States Department of Health and its office BARDA (Biomedical Advanced Research and Development Authority).
The French pharmaceutical company Sanofi has a team of scientists who are developing vaccines in the United States. Sanofi has historically developed a vaccine against SARS, a virus that also belongs to the coronavirus family. This vaccine should now be modified for Covid-19. Sanofi’s experience in this area could be an advantage in the vaccine race. This company also works with BARDA (Biomedical Advanced Research and Development Authority).
4. Gilead Sciences
Gilead is not working directly on a vaccine for Covid-19, but on the treatment of infected people. The goal here is to suppress the infection on the patient, speed up recovery and allow the patient to be released earlier. One patient has already been helped in the United States. The treatment is currently being tested in a clinical trial in Asia.
5. Regeneron Pharmaceuticals
The New York biotech company is working on a treatment to prevent new infections. Mouse antibodies are modified to mimic the human immune system. This is to avoid new infections. Regeneron says the drug is expected to reach the clinical phase of human testing in August.
Corona corporate course
Experts say it could take another year before a corona vaccine is approved for the public. The reason is that clinical studies must be conducted to rule out any risk from the vaccine. However, it should be beneficial to include the companies mentioned above in your watch list. The race will affect business prices, depending on who is the fastest to get there.
There are a few other companies working on developing a vaccine for Covid-2019, including Moderna Inc or the unlisted company of Tübingen Curevac. However, the above companies have significant partnerships and a lot of money is invested in them. And when developing a vaccine, he says:
Time is money, but money also reduces time.
Source Image: Pixabay